Skip to main content

Table 2 Causative pathogens identified at pretherapy/entry in the per-protocol bacteriologically evaluable (PPb) and bacteriologic modified intent to treat (bmITT) populations.

From: Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

Pathogen

Number of Isolates in PPb Patients

Number of Isolates in bmITT Patients

Total

204

337

S pneumoniae

57

76

H influenzae

49

88

H parainfluenzae

46

81

M catarrhalis

13

23

K pneumoniae

3

9

S aureus

15

23

Other*

21

37

  1. *Includes: Haemophilus haemolyticus (7); Haemophilus parahaemolyticus (7); Enterobacter cloacae (4); Pseudomonas aeruginosa (4); Acinetobacter baumannii (1 bmITT only); Citrobacter freundii (1 bmITT only); Enterobacter aerogenes (1); Enterobacter agglomerans (1 bmITT only); Enterobacter amnigenus (1 bmITT only); Enterobacter not otherwise specified (NOS) (1 bmITT only); Neisseria meningitides (1); Proteus mirabilis (1); Proteus NOS (1 bmITT only); Streptococcus, viridansgroup(5); Staphylococcus haemolyticus (1).
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us